Handok, has signed a domestic sales contract with i-SENS for continuous glucose monitoring devices.

  • 2024.04.29
  • 2454
Handok, has signed a domestic sales contract with i-SENS for continuous glucose monitoring devices.

On the 29th, Handok and i-SENS signed a sales contract for the domestic marketing and sales of continuous glucose monitoring devices at Handok’s headquarters in Yeoksam-dong. Through this agreement, Handok plans to launch the continuous glucose monitoring device developed by i-SENS as a product called Barozen Fit in May and plans to continuously introduce subsequent models.

The Barozen Fit continuous glucose monitoring device, which is scheduled to be released by Handok, allows users to freely enter glucose correction values, enabling more accurate glucose recording and management. Handok has been leading the market with its extensive experience and know-how in the diabetes market, based on its diverse portfolio. The company plans to rapidly expand its position in the continuous glucose monitoring market by creating synergy with its current diabetes solutions. To this end, Handok is preparing aggressive activities, including conducting symposiums for medical professionals both online and offline to broaden the base for continuous glucose monitoring devices, and strengthening marketing and sales using online channels.

Chairman Kim Young-jin of Handok stated, “Since forming a partnership in 2009, Handok and i-SENS have grown Barozen into a leading brand in the domestic glucose monitoring market, which was previously dominated by global companies.” He added, “Through this agreement, Handok will not only strengthen its position as a total diabetes solution company but also provide various options that can improve the quality of life for diabetes patients, in conjunction with Handok’s existing diabetes portfolio.”

i-SENS CEO Nam Hak-hyun expressed, “We expect that i-SENS’s continuous glucose monitoring device, developed with domestic technology, will further expand its position in the market through this agreement with Handok, which leads the domestic diabetes market.” He continued, “We will maintain and strengthen our partnership with Handok and introduce upgraded products that can manage diabetes more effectively.”


 
맨위로